Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients
辉瑞(US:PFE) Reuters·2025-10-18 14:37药物临床结果 - 辉瑞与日本公司Astellas的药物Padcev联合默克的Keytruda，降低了某种膀胱癌患者的肿瘤复发、进展或死亡风险 [1]
辉瑞(US:PFE) Reuters·2025-10-18 14:37辉瑞(US:PFE) Reuters·2025-10-18 14:37